Found: 18
Select item for more details and to access through your institution.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 156, doi. 10.1002/ajh.25677
- By:
- Publication type:
- Article
Facing erythrocytosis: Results of an international physician survey.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. E225, doi. 10.1002/ajh.25545
- By:
- Publication type:
- Article
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 9, p. 918, doi. 10.1002/ajh.24442
- By:
- Publication type:
- Article
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 681, doi. 10.1002/ajh.24377
- By:
- Publication type:
- Article
Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.
- Published in:
- Molecules, 2021, v. 26, n. 13, p. 3866, doi. 10.3390/molecules26133866
- By:
- Publication type:
- Article
Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. 573, doi. 10.1016/j.clml.2021.04.014
- By:
- Publication type:
- Article
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4970, doi. 10.3390/curroncol29070395
- By:
- Publication type:
- Article
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 475, doi. 10.1002/jha2.425
- By:
- Publication type:
- Article
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 2, p. 93, doi. 10.1111/j.1600-0609.2010.01558.x
- By:
- Publication type:
- Article
Epigenetic therapy in myelodysplastic syndromes.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 6, p. 463, doi. 10.1111/j.1600-0609.2010.01433.x
- By:
- Publication type:
- Article
A journey through infectious risk associated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 286, doi. 10.1111/bjh.16174
- By:
- Publication type:
- Article
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 8166, doi. 10.1002/cam4.5618
- By:
- Publication type:
- Article
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosis.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 589, doi. 10.1002/hon.2903
- By:
- Publication type:
- Article
Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 554, doi. 10.1002/hon.2769
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 2, p. i, doi. 10.1002/hon.2733
- By:
- Publication type:
- Article
Myeloproliferative and lymphoproliferative disorders: State of the art.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 841, doi. 10.1007/s00277-023-05113-9
- By:
- Publication type:
- Article
Tracing the decision-making process for myelofibrosis: diagnosis, stratification, and management of ruxolitinib therapy in real-word practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article